Currículum

Jesús Soberino García

Oncología Médica
Publicaciones
Atezolizumab in the treatment of metastatic triple-negative breast cancer.
Journal Article
Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy.
Clinical Trial, Phase II, Journal Article
Pembrolizumab plus eribulin in hormone-receptor-positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase ? trial.
Journal Article